Terns Pharmaceuticals Inc... (TERN)
NASDAQ: TERN
· Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.12
0.78%
After-hours: Aug 15, 2025, 06:54 PM EDT
Terns Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 145.97M | 139.02M | 161.44M | 270.14M | 91.5M | 65.1M | 79.93M | 37.89M | 80.92M | 184.35M | 143.24M | 62.98M | 16.81M | 43.88M | 47.7M | 64.75M | 67.59M | 98.83M |
Short-Term Investments | 169.48M | 195.24M | 196.72M | 102.64M | 133.8M | 175.56M | 183.51M | 228.71M | 204.68M | 113.17M | 139.88M | 124.31M | 123M | 107.39M | 118.28M | 112.44M | 117.5M | 96.75M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 356K | 351K | 350K | 56K | 55K | 55K | 56K | 35K | 36K | 2.17M | 37K | 47K | 64K | 72K | 94K | 169K | 176K | 174K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.51M | 3.48M | 3.94M | 3.73M | 4.94M | 5.24M | 3.99M | n/a | 2.71M | 2.14M | 2.07M | 3.25M | 2.79M | 2.84M | 948K | 1.6M | 1.79M | 2.46M |
Total Current Assets | 318.95M | 337.75M | 362.11M | 376.51M | 230.24M | 245.9M | 267.43M | 270.45M | 288.31M | 297.53M | 285.19M | 190.54M | 142.6M | 154.11M | 166.93M | 178.79M | 186.87M | 198.04M |
Property-Plant & Equipment | 1.11M | 1.22M | 1.47M | 1.67M | 587K | 816K | 1.03M | 1.2M | 1.35M | 1.58M | 1.8M | 2M | 2.19M | 2.49M | 1.05M | 927K | 959K | 1.02M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.46M | 1.57M | 1.82M | 1.73M | 642K | 871K | 1.08M | 1.23M | 1.38M | 3.76M | 1.84M | 2.05M | 2.26M | 2.56M | 1.14M | 1.1M | 1.14M | 1.2M |
Total Assets | 320.42M | 339.31M | 363.93M | 378.23M | 230.88M | 246.77M | 268.52M | 271.69M | 289.7M | 301.29M | 287.03M | 192.59M | 144.86M | 156.67M | 168.07M | 179.89M | 188.01M | 199.24M |
Account Payables | 2.85M | 2.78M | 2.15M | 1.79M | 1.87M | 1.7M | 2.52M | 3.33M | 5.54M | 2.69M | 1.65M | 2.09M | 973K | 1.68M | 2.13M | 1.58M | 1.69M | 4.25M |
Deferred Revenue | n/a | n/a | n/a | n/a | 2.05M | 1.22M | n/a | 7.66M | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | 836K | 836K | 836K |
Short-Term Debt | 444K | n/a | n/a | n/a | 249K | n/a | 603K | n/a | 653K | 656K | n/a | 665K | 586K | 584K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 6.41M | 3.19M | 5.16M | 4.76M | 5.48M | 532K | 5.36M | 4.36M | 5.61M | 7.28M | 185K | 2.06M | 2.58M | 2.64M | 358K | 3.08M | 2.34M | 2.79M |
Total Current Liabilities | 12.91M | 10.94M | 15.65M | 11.41M | 10.96M | 8.83M | 11.94M | 12.09M | 14.24M | 12.11M | 8.47M | 7.48M | 6.04M | 6.17M | 6.82M | 6.89M | 5.82M | 8.38M |
Long-Term Debt | 689K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.58M | 1.53M | 1.49M | 1.32M | 1.24M | 1.22M | 1.21M | 1.11M | 1.09M | 1.11M | 1.07M | 709K | 749K | 788K | 947K | 841K | 857K | 862K |
Total Long-Term Liabilities | 2.27M | 2.34M | 2.41M | 2.35M | 1.24M | 1.22M | 1.21M | 1.18M | 1.31M | 1.49M | 1.61M | 1.41M | 1.6M | 1.79M | 947K | 841K | 857K | 862K |
Total Liabilities | 15.19M | 13.27M | 18.06M | 13.76M | 12.2M | 10.05M | 13.15M | 13.26M | 15.55M | 13.6M | 10.08M | 8.89M | 7.64M | 7.95M | 7.77M | 7.73M | 6.67M | 9.24M |
Total Debt | 1.13M | 1.24M | 1.35M | 1.3M | 249K | 427K | 603K | 770K | 876K | 1.04M | 1.21M | 1.37M | 1.44M | 1.58M | n/a | n/a | n/a | n/a |
Common Stock | 9K | 9K | 9K | 8K | 7K | 6K | 6K | 6K | 6K | 5K | 5K | 4K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -469.48M | -445.39M | -421.48M | -399.68M | -377.74M | -355M | -332.63M | -311.61M | -281.84M | -263.95M | -242.42M | -226.6M | -209.78M | -195.85M | -182.07M | -167.82M | -155.99M | -145.25M |
Comprehensive Income | -22K | 51K | -279K | 160K | -443K | -321K | -19K | -836K | -775K | -416K | -822K | -1.35M | -1.24M | -896K | -338K | -167K | -174K | -232K |
Shareholders Equity | 305.23M | 326.04M | 345.87M | 364.47M | 218.68M | 236.72M | 255.37M | 258.43M | 274.15M | 287.68M | 276.94M | 183.69M | 137.22M | 148.72M | 160.3M | 172.16M | 181.33M | 190M |
Total Investments | 169.48M | 195.24M | 196.72M | 102.64M | 133.8M | 175.56M | 183.51M | 228.71M | 204.68M | 113.17M | 139.88M | 124.31M | 123M | 107.39M | 118.28M | 112.44M | 117.5M | 96.75M |